Male Urethral Stricture Disease

Published In: Urologic Diseases In America / Edited By Mark S. Litwin and Christopher S. Saigal (Washington, D.C.: US Department of Health and Human Services, Public Health, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2007), Chapter 16, p. 533-551, NIH Pub. no. 07-5512

Posted on RAND.org on January 01, 2007

by Richard A. Santucci, Geoffrey F. Joyce, Matthew Wise

Read More

Access further information on this document at www.kidney.niddk.nih.gov

This article was published outside of RAND. The full text of the article can be found at the link above.

The true incidence of male urethral stricture disease is unknown, despite the fact that urethral strictures may have great negative impact on patients. The majority of stricture patients suffer from moderate complications such as irritative voiding symptoms, recurrent urinary tract infections, or the need for repeated urethral procedures (e.g., dilation or urethrotomy). A minority suffer severe sequelae such as acute urinary retention, renal failure, urethral carcinoma, Fournier's gangrene, or bladder failure resulting from long-standing obstruction. A table lists ICD-9 and CPT-4 codes used to identify urethral stricture disease and related procedures.

This report is part of the RAND Corporation external publication series. Many RAND studies are published in peer-reviewed scholarly journals, as chapters in commercial books, or as documents published by other organizations.

The RAND Corporation is a nonprofit institution that helps improve policy and decisionmaking through research and analysis. RAND's publications do not necessarily reflect the opinions of its research clients and sponsors.